Natalia Izycka
Overview
Explore the profile of Natalia Izycka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Izycka N, Zaborowski M, Ciecierski L, Jaz K, Szubert S, Miedziarek C, et al.
Int J Mol Sci
. 2023 Aug;
24(16).
PMID: 37628927
Cancer stem cells (CSCs) may contribute to an increased risk of recurrence in ovarian cancer (OC). Further research is needed to identify associations between CSC markers and OC patients' clinical...
2.
Izycka N, Rucinski M, Andrzejewska M, Szubert S, Nowak-Markwitz E, Sterzynska K
Int J Mol Sci
. 2023 Feb;
24(3).
PMID: 36768723
Recurrent disease and treatment-associated chemoresistance are the two main factors accounting for poor clinical outcomes of ovarian cancer (OC) patients. Both can be associated with cancer stem cells (CSCs), which...
3.
Izycka N, Sterzynska K, Januchowski R, Nowak-Markwitz E
Ginekol Pol
. 2019 May;
90(4):223-227.
PMID: 31059116
Ovarian cancer is the fifth leading cause of cancer-related deaths in women. Its high mortality rate results from lack of adequate and sensitive methods allowing for the detection of the...
4.
Banach P, Zaborowski M, Izycka N, Romala A, Nowak-Markwitz E
Ginekol Pol
. 2019 Apr;
90(3):141-147.
PMID: 30950003
Objectives: The early identification of patients who are being treated for low-risk gestational trophoblastic neoplasia (LRGTN) with single-agent chemotherapy, who are at high risk of developing chemoresistance, is of crucial...
5.
Magnowska M, Izycka N, Kapola-Czyz J, Romala A, Lorek J, Spaczynski M, et al.
Ginekol Pol
. 2018 May;
89(4):200-4.
PMID: 29781075
Objectives: Chemotherapy-induced peripheral neuropathy (CIPN) is a common chemotherapy side effect, but its prevention and treatment remains a challenge. Neurotoxicity may lead to dose limitation or even treatment discontinuation, and...
6.
Izycki D, Wozniak K, Izycka N
Prz Menopauzalny
. 2016 Sep;
15(2):112-6.
PMID: 27582686
The diagnosis of gynecological cancer and the following consequences of the treatment radically change the lives of cancer patients and their partners. Women experience negative consequences in terms of sexual,...
7.
Izycki D, Niezgoda A, Kazmierczak M, Piorunek T, Izycka N, Karaszewska B, et al.
Ginekol Pol
. 2016 Aug;
87(7):516-21.
PMID: 27504945
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent neurologic complications experienced by patients receiving antineoplastic drugs. Involvement of the peripheral nerves may have an important impact on daily...
8.
Gasiorowska E, Magnowska M, Izycka N, Warchol W, Nowak-Markwitz E
Ginekol Pol
. 2016 Jun;
87(4):260-4.
PMID: 27321096
Objectives: The incidence of endometrial cancer is constantly growing. More aggressive types of endometrial cancer as well as the incidence in younger women is being observed. More than 80% of...